Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1985 1
1986 1
1987 1
1988 1
1989 2
1990 1
1991 1
1992 3
1994 1
1997 1
2005 4
2006 4
2007 3
2008 1
2009 4
2010 2
2011 9
2012 6
2013 14
2014 13
2015 17
2016 9
2017 13
2018 8
2019 10
2020 17
2021 26
2022 16
2023 18
2024 17
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons N; ALMS Group. Dooley MA, et al. N Engl J Med. 2011 Nov 17;365(20):1886-95. doi: 10.1056/NEJMoa1014460. N Engl J Med. 2011. PMID: 22087680 Free article. Clinical Trial.
Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
Nabais Sá MJ, Storey H, Flinter F, Nagel M, Sampaio S, Castro R, Araújo JA, Gaspar MA, Soares C, Oliveira A, Henriques AC, da Costa AG, Abreu CP, Ponce P, Alves R, Pinho L, Silva SE, de Moura CP, Mendonça L, Carvalho F, Pestana M, Alves S, Carvalho F, Oliveira JP. Nabais Sá MJ, et al. Among authors: da costa ag. Clin Genet. 2015 Nov;88(5):456-61. doi: 10.1111/cge.12521. Epub 2014 Nov 10. Clin Genet. 2015. PMID: 25307543
How Long to Treat with Denosumab.
Costa AG, Bilezikian JP. Costa AG, et al. Curr Osteoporos Rep. 2015 Dec;13(6):415-20. doi: 10.1007/s11914-015-0295-7. Curr Osteoporos Rep. 2015. PMID: 26474564 Review.
Immunologic mediators profile in COVID-19 convalescence.
Silva-Junior AL, Oliveira LS, Dias S, Costa TCC, Xabregas LA, Alves-Hanna FS, Abrahim CMM, Neves WLL, Crispim MAE, Toro DM, Silva-Neto PV, Aponte DCM, Oliveira TC, Silva MCC, Matos MMM, Carvalho MPSS, Tarragô AM, Fraiji NA, Faccioli LH, Sorgi CA, Sabino EC, Teixeira-Carvalho A, Martins-Filho OA, Costa AG, Malheiro A. Silva-Junior AL, et al. Among authors: costa ag. Sci Rep. 2024 Sep 9;14(1):20930. doi: 10.1038/s41598-024-71419-x. Sci Rep. 2024. PMID: 39251702 Free PMC article.
Bone markers and osteoporosis therapy.
Bandeira F, Costa AG, Soares Filho MA, Pimentel L, Lima L, Bilezikian JP. Bandeira F, et al. Among authors: costa ag. Arq Bras Endocrinol Metabol. 2014 Jul;58(5):504-13. doi: 10.1590/0004-2730000003384. Arq Bras Endocrinol Metabol. 2014. PMID: 25166041 Review.
Bone turnover markers in primary hyperparathyroidism.
Costa AG, Bilezikian JP. Costa AG, et al. J Clin Densitom. 2013 Jan-Mar;16(1):22-7. doi: 10.1016/j.jocd.2012.11.004. J Clin Densitom. 2013. PMID: 23374737 Free PMC article. Review.
207 results